Drugs can lead to misinterpretation of results in clinical biochemistry either by interfering with the chemistry of the analytical procedure causing a spurious change in concentration, or by interfering with the physiology of the substance in question causing a true change in its concentration in vivo. The first attempts to co-ordinate efforts to lessen misinterpretation resulting from interference with the chemistry of the analytical procedure have been described (Wilding, 1978) . However, there still remains the problem of drug-induced, biological changes. It has been estimated, that whereas fewer than 20 % of the entries in the computer-listing of drug interferences by Young et al. (1972) related to analytical methods, more than 80 % were concerned with in vivo phenomena (Lingaerde et al., 1973) .
The problem
Drugs can lead to misinterpretation of results in clinical biochemistry either by interfering with the chemistry of the analytical procedure causing a spurious change in concentration, or by interfering with the physiology of the substance in question causing a true change in its concentration in vivo. The first attempts to co-ordinate efforts to lessen misinterpretation resulting from interference with the chemistry of the analytical procedure have been described (Wilding, 1978) . However, there still remains the problem of drug-induced, biological changes. It has been estimated, that whereas fewer than 20 % of the entries in the computer-listing of drug interferences by Young et al. (1972) related to analytical methods, more than 80 % were concerned with in vivo phenomena (Lingaerde et al., 1973) .
CASE EXAMPLE
A 50-year-old asthmatic man was admitted in cardiac failure and treated with digoxin. On admission the serum potassium was 3·7 mmol/l (normal range 3·6-5·0 mrnol/l), Three days later he suffered an acute asthmatic attack which was treated with intravenous salbutamol (10 p.g/min for 60 minutes). A sample taken after the attack showed hypokalaemia, serum potassium 2·8 mmol/l. The reflex action of the physicians was to interpret this result as a laboratory error. However, since hypokalaemia potentiates digoxin toxicity, caution prevailed and another specimen was sent for analysis. This time the potassium was 3·6 mmol/l, and when the next day a potassium of 3'8 rnmol/l was found, the physicians felt they were justified in attributing the 'hypokalaemia' of 2·8 mmol/I to laboratory error. Indeed, the laboratory would have been obliged to agree "'Present address: Biochemistry Department, University of Surrey, Guildford GU2 5XH. until recently when Leitch et al. (1976) demonstrated that intravenous salbutamol caused an acute hypokalaemic response.
A co-ordinated plan of action is required to lessen such drug interferences. The objects of the plan are:
To increase awareness of the problem To obtain quantitative data To communicate these data.
AWARENES'S OF THE PROBLEM
A current awareness of the literature is essential. Unfortunately, drug interferences are reported in a wide range of literature and it is impossible for anyone to peruse every journal each month. I suggest that Current Clinical Chemistry might take the initiative, and have a section devoted to drug, interferences.
The need for such a current awareness service can be appreciated by extrapolating from two computercompiled lists in the literature, both entitled-Effects of drugs on clinical laboratory tests. The first list (Young et al., 1972) contained 9000 entries and the second (Young et al., 1975) 16 ()()() entries. Depending upon whether the growth of new entries is linear or logarithmic we may expect between 28 ()()() and 42 ()()() entries in the year 1980 or between 73 ()()() and 2 ()()() ()()() entries by the year AD 2000. Clearly, one hopes this is an overestimate, but the fact remains that today there are 16 ()()() entries requiring our attention and the need to extract the most .mpcrtant of these and incorporate them in the routine practice of clinical biochemistry is self-evident.
Editors of journals could play an important role by scrutinising papers for drug-induced artefacts. For example, in one detailed report of the effect of frusemide on the serum urate concentration a patient was also receiving anticoagulants and aminophylline, both of which are alleged to influence interpretation of the serum urate (Christensen, 1964; Paulus et al., 44 1970) . It would be invidious to quote the reference to this particular author and journal as there are many similar examples.
Another valuable contribution by journals would bethe inclusion ofdrug interferencea in the 'key-word' system, as often an important drug-produced artefact is concealed by a more interesting message in the paper. Finally, before any new method is described editors should insist that it has been screened for interferences by common drugs.
Even if qualitative information is available the problem is still not resolved. Much of the data may be inconsequential because a drug is obsolete or the magnitude of the effect is clinically insignificant. For this reason, facts based on quantitative data are required.
QUANTITATIVE DATA
The most important requirement is to know the average effect produced by a typical dose of a drug under typical conditions of treatment in a typical patient. This sort of detailed information is beyond the scope of the comprehensive computer-list of Young et al. (1975) . For example, if this list is used to find the effect of thiazide diuretics on serum calcium, thiazides are reported to 'increase', 'decrease', and to 'have no effect' on the serum calcium ( Table 1 ). The brief notes to which Young et al. are restricted do not resolve this confusion and it is necessary to check the references provided to assess critically the relevance of these factors. (1973), a short list of the more important references to drug interferences was constructed. The assessment of importance was subjective but took into account the magnitude of the change caused by therapeutic concentrations of the drug under typical clinical conditions. Other factors looked for were substantial evidence for an effect, and whether the drug was in common use; in this way, many putative drug interferences were eliminated. One method of communicating this information to clinicians is described below.
COMMUNICATION OF INFORMATION ON DRUG INTERFERENCES
There are a number of ways in which information regarding drug interference can be communicated to clinicians and laboratory workers.
Co-operation with the Committee on Safety of Medicines (CSM)
It is proposed that assistance from the CSM should be sought in order to collate and communicate undesirable biochemical side effects which may lead to mismanagement of a patient.
Co-operation with the Association of the British Pharmaceutical Industry (A BPI)
The assistance of the ABPI should be sought in the promulgation of the information obtained through the data sheets, the British National Formulary, and the data inserts enclosed with the drugs.
The Association of Clinical Biochemists (ACB)
The ACB should play a role in keeping members up-to-date on the subject of drug interferences, possibly through Current Clinical Chemistry.
Drug information pharmacists
The average hospital biochemist is not very familiar with the pharmaceutical aspects of drug interference. The drug information pharmacist may be unaware of methodological variations and other details necessary to evaluate properly an alleged drug interference. An active collaboration between hospital biochemists and drug information pharmacists is therefore important if better understanding of this problem is to be achieved.
Patient investigation manual
It has been suggested that information on drug interferences should be communicated to clinicians through a patient investigation manual kept on each ward. The author feels that this would be useful but the disadvantage is that reviewing and updating such a book may be a time-eonsuming, expensive procedure, unlikely to be undertaken at intervals of less than one or two years.
Computers
The use of computers to lessen the incidence of drug interferences has been studied by Young (1976) and has also been advocated by Bold (1976) . The disadvantage of this sophisticated approach is that computer facilities are not available to all laboratories. patients were receiving the following drugs which influence interpretation: paracetamol (4); frusemide (3); frusemide and paracetamol (1); bendrofluazide (1); bendrofluazide and methyl dopa (1).
Whose job is it?
The question arises: 'Is it the responsibility of the hospital biochemist/chemical pathologist, the clinical pharmacologist, the information pharmacist, or the clinician himself, to be aware of misleading results caused by drugs?' Since the problem is by nature interdisciplinary, it is suggested that a team of Simplc normal-range stylc (Fill.la) 12·1 Simple non-quantitative data on drugs (Fig. I b 
Informative reporting
Information referring to drug interferences should be reported with the result as the clinician is aware of the patient's drug history. A trial of a technique using rubber stamps to print the serum urate reports, has been investigated, Fig. 1 . The quantitative information shown was summarised as described earlier. The four styles of report form shown in Fig. 1 , were circulated to local hospital doctors and general practitioners who were asked to indicate the style of reporting they preferred. The results are summarised in Table 2 . It was interesting that the most complex report form giving both quantitative data on drug interferences and pathological information was the style preferred. The least popular style was the simple normal-range type which is in common practice. Accordingly, the style shown in Fig. lc has been introduced for routine evaluation and it is proposed to extend this trial to other investigations. The true extent to which drugs mislead clinicians in their interpretation of laboratory investigations is difficult to assess but it may be greater than is generally imagined. For example, before informative reporting was introduced, it was found that of a batch of 15 analyses performed for serum urate, 10 representatives of all these professions should work together in conjunction with the CSM and the ABPI to decide on a policy to tackle the problem. The objectives ofthis team should be to obtain quantitative data on drug interferences and to devise means of communication. There are few who have the temerity, let alone the experience, to attempt to write a book describing the methods currently in use in clinical biochemistry laboratories. Varley's Practical Clinical Biochemistry has been one of the few works of this sort which has been truly successful and the profession has eagerly awaited the appearance of its fifth edition. Since Harold Varley has now retired he has called upon the assistance of two of his colleagues to help him with this edition, which is being prepared in two volumes, the second of which is the first to appear.
This volume is concerned with the clinical biochemistry of hormones, "'itamins and drugs, and poisons. The section on hormones deals adequately with thyroid function tests and catecholamines and the book is to be particularly recommended for the coverage of the hormones of the hypothalamic-pituitaryadrenal axis and of the reproductive system. These however are the only hormones which are dealt with and the section as a whole lacks any description of the important technique of radioimmunoassay. Presumably these major deficiencies will be rectified when volume 1 appears but they prevent this volume from standing on its own as a textbook of chemical endocrinology. The omission of any mention of the role of hyperprolactinemia as a cause of reproductive dysfunction is presumably a reflection of the relatively long time required to produce a book when compared with the rapid advances in knowledge in certain areas of biochemistry. In contrast the very full coverage given to measurement of the basal metabolic rate is rather excessive in view of modern practice.
The chapter on drugs and poisons is a readable and useful account of this topic, which should be adequate for district laboratories, although~he mention of the use of radioimm in drug analysis is an unf omission. The chapter on vit . little patchy, some topics recei1' • and adequate treatment, while especially vitamin D, are too mentioned.T hroughout the book the auth laudably included sections on tbe pretation and clinical relevance biochemistry tests and it is most that they have seen fit to inclu traditional and SI units when refc oncentrations and normal ranlllli. volume is well presented, containsat though not essential, appendix andl supplied with references to original • and further reading. It is a book. will be of great value to pl aboratory workers and c1inici should find a place in hospital and mental libraries. Its full valueJ however be realised until its . mentary volume is also available. ••
